Overview

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A clinical study to collect additional data in order to characterize the reduction in PSA with finasteride 1 mg, and its reversibility in men with androgenetic alopecia between the ages of 40 to 60 years.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Finasteride